Targeting Hope Gala
Credit: OHSU News
Targeting Hope gala for the Knight Cancer Institute in September 2013. Katie Knudson (second from left) and her family celebrate with Brian Druker, M.D., right, after Phil Knight announces his $1 billion cancer challenge at the Targeting Hope gala in September 2013. At age 6, Knudson was one of the first children to receive Gleevec, the targeted cancer therapy that was developed by Dr. Druker. (OHSU)